These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 10077159)

  • 1. Spheroid assay to measure TGF-β-induced invasion.
    Naber HP; Wiercinska E; Ten Dijke P; van Laar T
    J Vis Exp; 2011 Nov; (57):. PubMed ID: 22126971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of galectin-1 expression by transforming growth factor beta1 in metastatic mammary adenocarcinoma cells: implications for tumor-immune escape.
    Daroqui CM; Ilarregui JM; Rubinstein N; Salatino M; Toscano MA; Vazquez P; Bakin A; Puricelli L; Bal de Kier Joffé E; Rabinovich GA
    Cancer Immunol Immunother; 2007 Apr; 56(4):491-9. PubMed ID: 16900348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cytomegalovirus glycoprotein B inhibits migration of breast cancer MDA-MB-231 cells and impairs TGF-β/Smad2/3 expression.
    Yang R; Liang J; Xu GX; Ding LM; Huang HM; Su QZ; Yan J; Li YC
    Oncol Lett; 2018 May; 15(5):7730-7738. PubMed ID: 29849800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Smad3 and reduced Smad2 levels mediate the functional switch of TGF-β from growth suppressor to growth and metastasis promoter through TMEPAI/PMEPA1 in triple negative breast cancer.
    Singha PK; Pandeswara S; Geng H; Lan R; Venkatachalam MA; Dobi A; Srivastava S; Saikumar P
    Genes Cancer; 2019; 10(5-6):134-149. PubMed ID: 31798766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of TGF-β signaling suppresses premature senescence in a p21-dependent manner and promotes oncogenic Ras-mediated metastatic transformation in human mammary epithelial cells.
    Lin S; Yang J; Elkahloun AG; Bandyopadhyay A; Wang L; Cornell JE; Yeh IT; Agyin J; Tomlinson G; Sun LZ
    Mol Biol Cell; 2012 Apr; 23(8):1569-81. PubMed ID: 22357622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nodal and activin receptor-like kinase 7 induce apoptosis in human breast cancer cell lines: Role of caspase 3.
    Zhong Y; Xu G; Ye G; Lee D; Modica-Amore J; Peng C
    Int J Physiol Pathophysiol Pharmacol; 2009 Feb; 1(1):83-96. PubMed ID: 21383881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of SnoN in transforming growth factor beta1-induced expression of metalloprotease-disintegrin ADAM12.
    Solomon E; Li H; Duhachek Muggy S; Syta E; Zolkiewska A
    J Biol Chem; 2010 Jul; 285(29):21969-77. PubMed ID: 20457602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual effects of TGF-beta on ERalpha-mediated estrogenic transcriptional activity in breast cancer.
    Ren Y; Wu L; Frost AR; Grizzle W; Cao X; Wan M
    Mol Cancer; 2009 Nov; 8():111. PubMed ID: 19943940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells.
    Luo X; Xu J; Chegini N
    Reprod Biol Endocrinol; 2003 Dec; 1():125. PubMed ID: 14678567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interfering with TGFbeta-induced Smad3 nuclear accumulation differentially affects TGFbeta-dependent gene expression.
    Lindemann RK; Nordheim A; Dittmer J
    Mol Cancer; 2003 Mar; 2():20. PubMed ID: 12747808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta signaling in mammary gland development and tumorigenesis.
    Wakefield LM; Piek E; Böttinger EP
    J Mammary Gland Biol Neoplasia; 2001 Jan; 6(1):67-82. PubMed ID: 11467453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signalling pathways involved in antiproliferative effects of IGFBP-3: a review.
    Baxter RC
    Mol Pathol; 2001 Jun; 54(3):145-8. PubMed ID: 11376125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta and breast cancer: Transforming growth factor-beta/SMAD signaling defects and cancer.
    Kretzschmar M
    Breast Cancer Res; 2000; 2(2):107-15. PubMed ID: 11250700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profile of agonistic Smads in human breast cancer cells: absence of regulation by estrogens.
    Pouliot F; Labrie C
    Int J Cancer; 1999 Mar; 81(1):98-103. PubMed ID: 10077159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC; de Caestecker MP; Schnaper HW
    Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study.
    Xie W; Mertens JC; Reiss DJ; Rimm DL; Camp RL; Haffty BG; Reiss M
    Cancer Res; 2002 Jan; 62(2):497-505. PubMed ID: 11809701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells.
    Chen WB; Lenschow W; Tiede K; Fischer JW; Kalthoff H; Ungefroren H
    J Biol Chem; 2002 Sep; 277(39):36118-28. PubMed ID: 12140283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transition of human breast cancer cells from an oestrogen responsive to unresponsive state.
    Darbre PD; Daly RJ
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):753-63. PubMed ID: 2285587
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.